In connection with the above, we aimed to quantify soluble E-cadherin and the secreted form of clusterin as well as the role of miRNAs as potential regulatory molecules in the expression levels of these compounds in the blood plasma of pregnant women with AIP of various levels of severity to assess the diagnostic value of each of them for use in clinical practice. The gene discussed is CLU; the disease is autoimmune pancreatitis.